. 2019 Jul 2;8(8):1089–1096. doi: 10.1530/EC-19-0303
This work is licensed under a Table 1.
Clinical and pathologic features of the patients (N = 106).
| N (%) | |
|---|---|
| Age at diagnosis, years (mean, 95% CI) | 54 (19–85) |
| Gender | |
| Females | 67 (63.2) |
| Males | 39 (36.8) |
| Histological diagnosis | |
| NH | 2 (1.9) |
| FA | 5 (4.7) |
| HA | 5 (4.7) |
| HTT | 6 (5.7) |
| PTC | 48 (45.3) |
| FTC | 12 (11.3) |
| HCC | 5 (4.7) |
| MTC | 9 (8.5) |
| PDTC | 6 (5.7) |
| ATC | 8 (7.5) |
| Stage (AJCC) | |
| NA | 19 (17.9) |
| I | 61 (57.5) |
| II | 12 (11.3) |
| III | 0 (0) |
| IV | 14 (13.3) |
| Metastases (lymph node + distant) | |
| Yes | 28 (26.4) |
| No | 60 (56.6) |
| NA | 18 (17) |
| Number of metastases | |
| Single | 13 (12.3) |
| Multiple | 13 (12.3) |
| NA | 80 (75.4) |
ATC, anaplastic thyroid carcinoma; FA, follicular adenoma; FTC, follicular thyroid carcinoma; HA, Hürthle cell adenoma; HCC, Hürthle cell carcinoma; HTT, hyalinizing trabecular tumor; MTC, medullary thyroid carcinoma; NA, not available; NH, nodular hyperplasia; PDTC, poorly differentiated thyroid carcinoma; PTC, papillary thyroid carcinoma.